RESEARCH USE ONLY
10 MG
Tesamorelin
10 MG
Certificate of Analysis
Batch HPLC & MS included
UK Dispatch
Shipped next working day
Research Grade
≥98% documented purity
Discreet Packaging
Plain, secure, tamper-evident
Laboratory Research Use Only: This compound is sold exclusively for qualified in-vitro scientific and laboratory investigation. Strictly not intended for human or veterinary administration.
Product Overview
Tesamorelin 10mg UK | Growth Hormone-Releasing Factor Research Peptide
Product: Tesamorelin 10mg
Price: £49.95
Category: Research Peptides
Availability: Check current stock status
Product Overview
Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), investigated for its effects on growth hormone signalling, insulin-like growth factor 1 (IGF-1), and metabolic regulation. Its mechanism of action makes it relevant to laboratory research exploring endocrine signalling and body-composition biology.
Research-Chem.uk offers Tesamorelin 10mg for laboratory research purposes. This product is intended exclusively for controlled scientific investigation and is not supplied for human or veterinary use.
Product Highlights
- **Compound:** Tesamorelin
- **Quantity:** 10mg
- **Price:** £49.95
- **Peptide class:** Synthetic GHRH analogue
- **Research focus:** Growth hormone signalling and metabolic pathways
- **Quality documentation:** Refer to the applicable batch Certificate of Analysis (CoA) for verified analytical results
What Is Tesamorelin?
Tesamorelin is a modified, 44-amino-acid synthetic peptide based on human growth hormone-releasing hormone. The molecule incorporates a modification at its N-terminal region intended to improve stability against enzymatic degradation compared with native GHRH.
GHRH is involved in regulating the synthesis and release of growth hormone from pituitary somatotroph cells. By interacting with GHRH receptors, Tesamorelin has been studied for its ability to stimulate endogenous growth hormone secretion and influence downstream signalling, including IGF-1.
Unlike compounds that directly supply growth hormone, Tesamorelin acts through a receptor-mediated signalling pathway. This distinction makes it a useful subject for research examining the relationship between hypothalamic-pituitary signalling, growth hormone release, and metabolic physiology.
How Does Tesamorelin Work?
Tesamorelin is investigated primarily for its interaction with the growth hormone-releasing hormone receptor and the downstream biological responses associated with that pathway.
1. GHRH Receptor Signalling
Tesamorelin binds to GHRH receptors on pituitary cells involved in growth hormone production. Research has examined how this interaction influences growth hormone synthesis and release.
2. Growth Hormone and IGF-1 Pathways
Growth hormone can influence the production of insulin-like growth factor 1 (IGF-1), a signalling molecule involved in growth, tissue physiology, and metabolic processes. Tesamorelin research therefore provides a model for investigating the relationship between GHRH receptor activation, growth hormone secretion, and IGF-1 signalling.
3. Lipid Metabolism and Body Composition
Clinical studies of prescription tesamorelin formulations have examined changes in visceral adipose tissue in adults with HIV-associated lipodystrophy. These findings provide a clinical evidence base for studying the relationship between growth hormone signalling and fat metabolism in specific populations.
Results from those prescription-drug studies should not automatically be extrapolated to this research product or other populations.
What Does Research Say About Tesamorelin?
Tesamorelin has been investigated in both mechanistic studies and controlled clinical trials.
Published clinical research has demonstrated that prescription tesamorelin can reduce visceral adipose tissue in adults with HIV-associated lipodystrophy. This is a specific clinical indication and should not be interpreted as evidence that Tesamorelin is a general-purpose weight-loss treatment.
Research has also examined changes in growth hormone and IGF-1 levels, alongside metabolic and body-composition measurements. These outcomes depend on the study population, formulation, research design, and measured endpoint.
Important considerations include:
- **Clinical evidence:** Controlled human studies exist for prescription tesamorelin in a defined medical population.
- **Mechanistic research:** GHRH receptor activation and downstream growth hormone signalling are central areas of investigation.
- **Limitations:** Evidence for an approved prescription formulation does not establish the quality, safety, effectiveness, or suitability of a separate research-grade product.
- **Safety considerations:** Growth hormone and IGF-1 signalling can affect glucose regulation and other physiological processes. Prescription product information includes clinically significant warnings and monitoring considerations.
Tesamorelin is not indicated in its approved US prescription labelling as a general weight-management treatment. Research-Chem.uk does not make therapeutic or weight-loss claims for this product.
Research References
The following sources provide background on Tesamorelin’s mechanism and clinical research:
1. **US Food and Drug Administration – Egrifta WR Prescribing Information.** Official information on the approved prescription formulation, indication, mechanism of action, limitations of use, and safety considerations.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022505s020lbl.pdf
2. **Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy.** Review of clinical evidence, including Phase 3 trials and findings relating to visceral adipose tissue.
https://pubmed.ncbi.nlm.nih.gov/22298602/
3. **US FDA – Clinical Pharmacology Review for Tesamorelin.** Background on molecular structure, GHRH receptor activity, and the original clinical development programme.
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000ClinPharmR.pdf
These references describe published research and prescription-drug information; they do not independently verify the identity, purity, or quality of the specific product offered on this page.
Product Specifications
Specification Details
Product name : Tesamorelin
Stated quantity : 10mg
Price : £49.95
Compound type : Synthetic peptide analogue
Peptide class : Growth hormone-releasing hormone analogue
Primary research area : GHRH receptor and growth hormone signalling
Additional research area : IGF-1 and metabolic pathways
Analytical documentation : Refer to the applicable batch CoA
ntended use : Laboratory research only
**Purity and analytical testing:** Product-specific purity, identity, and testing details should be stated only where supported by the current batch documentation. Please consult the relevant Certificate of Analysis for available analytical results.
Quality and Purity
Research-Chem.uk recognises the importance of analytical traceability when sourcing research compounds. Product quality should be evaluated using documentation relevant to the actual batch supplied.
Where available, the batch Certificate of Analysis may provide information on:
- Analytical identity and compound confirmation
- Reported purity and the method used to determine it
- Batch or lot identification
- Testing laboratory and report date
- Relevant handling and storage information
Analytical methods such as high-performance liquid chromatography (HPLC) can help assess chromatographic purity. However, a purity result alone does not establish sterility, endotoxin status, biological activity, or suitability for administration. Do not assume a particular purity percentage or independent laboratory certification unless the applicable documentation confirms it.
Laboratory Research Applications
Tesamorelin may be relevant to controlled laboratory investigations involving:
- GHRH receptor interactions and signal transduction
- Growth hormone secretion pathways
- Growth hormone and IGF-1 relationships
- Endocrine regulation and metabolic physiology
- Research models examining lipid metabolism and body composition
These are areas of scientific investigation, not claims of benefit from using this productWhy Choose Research-Chem.uk?
Research-Chem.uk aims to provide clearly described research compounds with transparent product information and appropriate quality documentation.
When evaluating any research peptide, we recommend reviewing the product specifications, batch-specific analytical documentation, and applicable research-use limitations before use in a laboratory setting.
Important Research-Use Disclaimer
Tesamorelin 10mg is offered strictly for laboratory research purposes. **It is not intended for human consumption, self-administration, injection, diagnosis, treatment, prevention of disease, or veterinary use.**
This listing is not medical advice and does not represent a claim that this product is equivalent to an authorised prescription medicine. Clinical findings associated with prescription tesamorelin formulations must not be interpreted as proof of safety or effectiveness for this research product.
Purchasers are responsible for ensuring that their research activities comply with applicable laws, institutional requirements, and laboratory safety procedures.
| Key Product Features | |
|---|---|
| Product | Tesamorelin |
| Vial Quantity | 10 MG |
| Purity Threshold | ≥98.0% (HPLC) |
| Physical Form | White lyophilised powder |
| Documentation | Batch-specific Certificate of Analysis (COA) |
| Intended Application | In-vitro scientific laboratory research only |
| Origin / Dispatch | United Kingdom (Shipped next working day) |
Tesamorelin Product Specifications
Primary Sequence:
GHRH receptor and growth hormone signalling
| Specification | Details |
|---|---|
| Product Name | Tesamorelin |
| Stated Purity | ≥98.0% (HPLC) |
| Peptide Sequence | GHRH receptor and growth hormone signalling |
| Solvent Matrix | Bacteriostatic or sterile water for injection |
| Appearance | White lyophilised powder |
| Storage Specification | −20 °C long-term; 2–8 °C short-term |
| Testing Method | High-Performance Liquid Chromatography (HPLC) & Mass Spectrometry (MS) |
| Analytical Documentation | Batch-specific Certificate of Analysis (COA) |
| Intended Application | Laboratory research use only (in-vitro) |
Quality and Analytical Standards
At Research-Chem.uk, analytical quality, purity verification, and batch traceability are paramount across our entire research catalogue.
Every batch of Tesamorelin undergoes rigorous analytical evaluation via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to verify molecular mass, peptide sequence integrity, and chemical purity. Batch-specific Certificates of Analysis (COA) are provided for qualified laboratory record-keeping and audit compliance.
Our quality-assurance framework guarantees reproducible standards for scientific investigation, analytical assay development, and academic research.
Laboratory Research Applications
Tesamorelin is supplied exclusively as a reference compound for controlled in-vitro scientific research. Documented experimental applications include:
- In-vitro cellular signalling and biochemical pathway investigations
- Analytical assay validation and high-performance chromatographic reference standardisation
- Receptor binding affinity and enzyme kinetic profiling
- Molecular interaction and quantitative cellular response studies
Strictly not for clinical diagnostic procedures, therapeutic administration, or any form of in-vivo human or veterinary testing.
Why Choose Research-Chem.uk?
HPLC-Verified Purity
Every research compound is verified with chromatographic analysis and supplied with batch-specific purity documentation.
Batch Traceability
Comprehensive documentation and Certificate of Analysis (COA) reports accompany research lots for full experimental reproducibility.
UK Domestic Dispatch
Dispatched directly from within the United Kingdom for reliable, prompt domestic transit in temperature-controlled packaging.
Research-Only Standard
Dedicated strictly to qualified academic, clinical, and industrial research environments.
Transparent Specifications
Full disclosure of molecular weight, CAS registry, purity threshold, and chemical storage recommendations.
Research-Use Disclaimer
For laboratory research use only. Strictly not for human or veterinary administration.
Tesamorelin supplied by Research-Chem.uk is intended exclusively for in-vitro scientific study, analytical testing, and laboratory evaluation.
This compound is not a medication, drug, medical device, dietary supplement, or cosmetic. It is not approved by regulatory authorities for the diagnosis, treatment, cure, mitigation, or prevention of any disease or condition in humans or animals.
Purchasers are solely responsible for ensuring handling, storage, and laboratory utilization comply with all relevant UK statutory provisions, COSHH assessments, and institutional safety regulations.
